Mode
Text Size
Log in / Sign up

Chikungunya seroprevalence was 34.3% overall, significantly higher in urban Colombo communities compared to semi-urban areasA Silent Threat Reawakens: Why a Major City Was Primed for an Outbreak

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note higher chikungunya seroprevalence in urban Colombo settings prior to the 2024 outbreak, suggesting environmental drivers of transmission.

This observational cohort study evaluated the seroprevalence of chikungunya virus infection among 1,196 participants residing in urban and semi-urban communities within Colombo, Sri Lanka, between September and November 2024. The primary outcome measured was age-stratified seroprevalence of chikungunya-specific IgG antibodies, reflecting past exposure rather than active infection. The study population included 816 residents from urban areas and 380 from semi-urban communities.

Overall chikungunya IgG seropositivity was 34.3% (410 of 1,196 participants). Seroprevalence was significantly higher in urban populations (39.6%) compared to semi-urban populations (22.9%), with an adjusted odds ratio of 7.48 (95% CI 4.05 to 13.81; p<0.001) for living in an urban area. Conversely, the use of mosquito nets was associated with a reduced risk of seropositivity, with an adjusted odds ratio of 0.50 (95% CI 0.27 to 0.93; p=0.029). Seroprevalence in individuals aged under 16 years was minimal at 0.55%.

No adverse events, discontinuations, or data on tolerability were reported, as this was a serological survey rather than an interventional trial. Key limitations include the observational nature of the study, which precludes causal inference regarding environmental or behavioral factors. Additionally, the study was conducted prior to the 2024 outbreak, meaning seroprevalence reflects historical exposure rather than current infection status. Generalizability beyond Colombo, Sri Lanka, is uncertain. These results highlight the potential role of population density and housing conditions in transmission dynamics.

Imagine a virus that causes such severe joint pain it can leave you curled up for weeks. Now, imagine that virus disappearing from a community for over a decade and a half. The danger isn't gone. It's just waiting for the right conditions to strike again.

That's exactly what happened in Colombo, Sri Lanka.

The virus is chikungunya. It's spread by mosquito bites.

The illness is known for causing high fever and debilitating joint pain. For some, that pain can last for months or even years. It's a major public health threat in tropical and subtropical regions.

Until late 2024, Sri Lanka hadn't seen a major outbreak since 2008. For 16 years, cases were rare. This long quiet period created a critical question.

Had people built up immunity? Or was the population a sitting duck?

The Surprising Shift

The old assumption was simple. No outbreak means no problem.

But here's the twist. No outbreak for a long time can create a bigger problem. It means fewer people have been exposed. It means immunity in the community fades away.

A new, large population grows up with no protection at all. The virus finds a city full of potential hosts.

How Vulnerability Spreads

Think of immunity like a shield. When enough people in a community have this shield, the virus hits a dead end. This is called herd immunity.

After 16 years with little virus circulating, that shield wall crumbled. The study acted like a snapshot, checking who still had their shields up by looking for antibodies in the blood.

They took this snapshot just months before a large outbreak began in December 2024. What they found was a map of vulnerability.

Researchers tested nearly 1,200 people in urban and semi-urban parts of Colombo between September and November 2024. They collected blood samples and asked about living conditions and health. Their goal was to see how many people had signs of a past chikungunya infection.

The results were stark. Overall, only about 34% of people had antibodies to chikungunya. That means roughly two-thirds of the population had no immune shield against it.

The gap between city and suburb was enormous. In dense urban areas, 39.6% were protected. In semi-urban areas, it was just 22.9%.

Most startling was the age data. Almost no one under 16 years old had any protection. The rate was a mere 0.55%.

This proved the virus had barely circulated since the last big outbreak 16 years prior. An entire generation had grown up vulnerable.

The Urban Risk Factor

But there's a catch.

Living in an urban area was the single biggest risk factor for having been infected in the past. People in the city were over seven times more likely to have encountered the virus than those in semi-urban settings.

The reason? Higher population density, overcrowding, and poorer housing conditions. These factors create a perfect playground for mosquitoes to spread the virus from person to person.

There was also a clear sign of what helps. Using a mosquito net was independently linked to a 50% lower risk of past infection.

Connecting to Chronic Health

The study revealed another layer. In the urban group, a past chikungunya infection was more common in people with certain chronic conditions.

These included diabetes, high blood pressure, central obesity, and being overweight. This doesn't mean the virus causes these conditions. Instead, it may highlight how living conditions that increase mosquito exposure might also influence other health risks.

It's a sign that public health threats are often interconnected.

This type of study is a vital early warning system for epidemiologists. It shows that seroprevalence studies—testing blood for antibodies—can identify "hotspots" of susceptibility before an outbreak strikes. This information is gold for planning where to focus mosquito control and, eventually, vaccination campaigns.

This does not mean a new outbreak is imminent where you live. This was a specific study of Colombo, Sri Lanka.

The crucial lesson is about preparedness. For public health officials in regions prone to mosquito-borne diseases, the study is a blueprint. It shows the power of testing community immunity to see where the next outbreak might ignite.

For individuals, the practical advice remains critical: use insect repellent, wear long sleeves, and use mosquito nets where recommended. Eliminate standing water around your home where mosquitoes breed.

The Study's Limits

This study has important limitations. It was done in one region, so the findings are specific to that area. It shows a link between urban living and infection risk, but it can't prove one directly caused the other. Finally, it was conducted before the outbreak, so we can't see how these vulnerability maps played out in real time.

The findings arrived just as the outbreak began, providing a tragic real-time validation of the warning. The next steps are about application. This research strengthens the case for proactive, geographic-based surveillance.

It helps answer where to deploy resources first when a new vaccine becomes widely available. The goal is to move from reacting to outbreaks to preventing them. While that future is still being built, this study provides a powerful map to guide the way.

Study Details

Study typeCohort
Sample sizen = 816
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Introduction: Following a large chikungunya outbreak during 2006 to 2008, Sri Lanka did not report any outbreaks for a 16 year period until end of 2008, possibly due to population immunity. Therefore, understanding baseline immunity prior to outbreaks is crucial to inform implementation of vaccine strategies. Methods: We assessed the age stratified seroprevalence for chikungunya in an urban (n=816) and a semi urban (n=380) community in Colombo, Sri Lanka, from September to November 2024, prior to the commencement of the large chikungunya outbreak, in December 2024. Sociodemographic, socioeconomic and clinical data were collected and chikungunya specific IgG measured in serum samples. Results: Of 1196 participants, 410 (34.3%) were chikungunya IgG seropositive. Seroprevalence was significantly higher in urban populations compared with semi urban populations (39.6% vs 22.9%; p<0.001) and increased significantly with age in urban areas but not in semi-urban areas. Living in an urban area was the strongest independent risk factor of chikungunya seropositivity (aOR 7.48, 95% CI 4.05 to 13.81; p<0.001), consistent with the higher population density, poor housing conditions and overcrowding observed in that setting. The use of mosquito nets was independently associated with reduced risk of seropositivity (aOR 0.50, 95% CI 0.27 to 0.93; p=0.029). Almost no individuals aged <16 years had evidence of prior infection (0.55%), indicating minimal transmission in the preceding 16 years. In the urban cohort, seropositivity was significantly associated with diabetes, central obesity, overweight, and hypertension. Conclusions: There appears to have been minimal chikungunya transmission in the 16 years preceding the 2024 outbreak, with a large population susceptible to chikungunya. Higher seroprevalence in urban populations highlights the role of population density, overcrowding, and housing conditions as key drivers of transmission.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.